| |
siRNA Id: | aspsirna3446
|
siRNA Name: | sh39Ap16
|
Gene: | Hungtintin (HTT) |
Disease: | Huntington disease (HD) |
Wild allele/target (5'->3'): | GUACUUCAACGCUAGAA
|
Mutant allele/target (5'->3'): | GUAAUUCAACGCUAGAA
|
Target Mutation: | NM_002111.7:c.5165C>A
|
Wild siRNA (As strand): | CAUGAAGUUGCGAUCUU
|
ASP-siRNA (As strand): | CAUUAAGUUGCGAUCUU
|
Mismatch position in siRNA: | U16G |
Mutant allele (5'->3'): | GUAAUUCAACGCUAGAA
|
ASP-siRNA (As strand): | CAUUAAGUUGCGAUCUU
|
ASP-siRNA efficacy for mutant allele: | 100
|
Wild allele (5'->3'): | GUACUUCAACGCUAGAA
|
ASP-siRNA (As strand): | CAUUAAGUUGCGAUCUU
|
ASP-siRNA efficacy for wild allele: | 40
|
Percentage discrimination for ASP-siRNA: | 60
|
Wild allele (5'->3'): | GUACUUCAACGCUAGAA
|
Wild siRNA (As strand): | CAUGAAGUUGCGAUCUU
|
Wild sirna efficacy for wild allele: | 88
|
Wild allele (5'->3'): | GUACUUCAACGCUAGAA
|
ASP-siRNA (As strand): | CAUUAAGUUGCGAUCUU
|
Wild sirna efficacy for mutant allele: | 15
|
Percentage discrimination for wild siRNA: | 73
|
Concentration: | 6nM |
Orientation: | Double strand |
Mismatch in: | siRNA |
UniProt ID: | P42858 |
Target sequence: | AGCTTTGATGGATTCTAA |
Genbank Accesion: | NM_002111.7 |
Cell-line: | HEK293T |
Experimental technique used: | Western blot |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Invitrogen |
Post-transfection duration: | 48 hours |
OMID ID: | 143100 |
KEGG disease ID: | H00059 |
Reference: | 24926995 |